Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

RENN Health vs Science & Co

By GLP-1 ScorecardUpdated

RENN HealthFactor scores not reassessed.
Site position #143

Lower score

Science & CoFactor scores not reassessed.
Site position #82

Higher score

Score comparison

Science & Co has the higher recorded score — 72.9/100 to 69.3/100.

Science & Co grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. States in its own footer that it is not a compounding facility, and explains its own asterisk in its own FAQ — two things almost nothing else here does.

Before you choose

Before comparing the headline prices, the RENN Health review and the Science & Co review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, RENN Health vs Trellis Vitality and Rylo Health vs Science & Co compare each of them with another graded program, and the list of alternatives to RENN Health ranks the programs closest to RENN Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEven
74
74
Dose & formulationScience & Co +10
64
74
Clinical oversightScience & Co +3
73
76
Labs & monitoringScience & Co +3
52
55
FulfillmentRENN Health +13
93
80
Contract termsScience & Co +27
55
82
RENN Health · top barScience & Co · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricRENN HealthScience & Co
WeighScore69.3/10072.9/100
GradeCC
Site position#143#82
SemaglutideFrom $149/mo (the site's own floor; it publishes no billing cycle and no standing rate)$149/mo month-to-month ($79 only on a 12-month plan)
TirzepatideFrom $199/mo (the site's own floor; it publishes no billing cycle and no standing rate)$199/mo month-to-month ($125 only on a 12-month plan)
CoverageAll 50 statesNot publicly listed
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
RENN Health

Site position #143 · C

Factor scores not reassessed.

Strengths

  • Names six dispensing pharmacies with websites and phone numbers — Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills
  • Names two prescribing physicians with their NPI numbers and the medical group behind them, which almost nothing else at this price does
  • Prices a registered dietitian, the telehealth visit and overnight cold shipping at zero rather than adding them later
  • Care is stated as available to patients in all 50 U.S. states

What to consider

  • No refund, cancellation or auto-renewal terms exist anywhere on the site, on a subscription product sold with three- and six-month prepay bundles
  • “As low as $149” and “as low as $199” are floors with no billing cycle attached, and the site never states what the standing monthly rate is or what the floor requires
  • The memberships page ships placeholder text — “Membership 1 / short description placeholder” and the word Placeholder where a price belongs — and it is in the site's own sitemap
  • The word compounded never appears on the marketing site; the disclosure exists only in an interface the patient does not see
  • Semaglutide and tirzepatide tablets are marked visible in the patient's own intake catalog and appear nowhere on the public site
  • The Terms carry two governing-law clauses that name different jurisdictions
  • Belmar, one of the six named dispensing pharmacies, is the subject of an FDA warning letter issued March 2023 to “Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy”, which the FDA closed out in October 2023. It concerns a supplier; RENN Health carries no warning letter of its own
  • No compounding class is stated for any of the six pharmacies
Science & Co

Site position #82 · C

Factor scores not reassessed.

Strengths

  • States twice in its footer that "Science and Co, Inc. is not a 503A or 503B compounding facility"
  • Its own FAQ names the commitment behind the headline: "Plans start at $125 a month on the 12 month plan"
  • The printed saving corroborates the reference price — 125 divided by 199 is 63%, exactly the "Save 37%" shown
  • "Same Price, Any Dose", with no hidden fees, no monthly membership and free shipping stated in the FAQ
  • Names its operating entity and state of incorporation, and says every batch is third-party tested

What to consider

  • The number it leads with is a twelve-month commitment; the per-month rates are $149 and $199
  • Only two figures are published per drug, so a three- or six-month plan cannot be priced without starting an intake
  • It says it is not a compounding facility but never names the pharmacy that is
  • No lab or monitoring protocol is published
  • Injection only on the pages read — no oral route and no brand lane

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard